U.S. fines J&J $9.75 million over kickbacks to surgeon for overseas surgeries
Reuters
Published Jan 20, 2023 03:18PM ET
By Jonathan Stempel
(Reuters) - Johnson & Johnson (NYSE:JNJ) and its DePuy Synthes unit will pay $9.75 million to settle U.S. Department of Justice accusations that DePuy illegally provided free products to a Massachusetts surgeon who used them in spinal surgeries in six Middle Eastern countries.
According to settlement papers, the surgeon used more than $100,000 of DePuy's implants and instruments between July 2013 and Feb. 2018 in more than 20 surgeries in Bahrain, Kuwait, Lebanon, Qatar, Saudi Arabia and the United Arab Emirates.
The Justice Department said DePuy provided the products to induce the surgeon to use its products in spinal surgeries he performed in Boston on patients who, unlike in the overseas surgeries, were covered by the government's Medicare and Medicaid health programs.
This activity violated the federal False Claims Act and an anti-kickback law meant to ensure that doctors act in their patients' best interests without being compromised by improper financial incentives, the Justice Department said.
The $9.75 million payment includes a $4.33 million fine and $5.42 million in restitution. A whistleblower, Aleksej Gusakovs, will receive about $1.85 million from the settlement. The Justice Department credited DePuy for cooperating in the probe.
In a statement, DePuy said the settlement avoids further lengthy legal proceedings, and that it was "committed to ensuring our employees conduct business in a way that complies with our credo and with all laws and regulations."
The False Claims Act lets whistleblowers sue on behalf of the government, and share in recoveries. DePuy is based in Raynham, Massachusetts, and Johnson & Johnson in New Brunswick (NYSE:BC), New York.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.